drugset / Trial / NCT06090955

Modulating Surgery-Induced Blood-Brain Barrier Disruption in Elderly

NCT06090955 ↗

Unknown 108 enrolled Samsung Medical Center
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Postoperative delirium (POD) is the most common complications (\~50-60%) in elderly and major challenges to our rapidly growing aging population. Growing evidence suggests a possible role for neuroinflammation in the development of delirium, which is facilitated by a transient increase in blood-brain barrier (BBB) permeability. Lidocaine and dexmedetomidine, commonly used anesthetic adjuncts, have anti-inflammatory properties. Both drugs are reported to have modulatory effect on the intergrity of BBB and associated with a beneficial effect on postoperative neurocognitive dysfunction. In this regard, The investigators aimed to prospectively compare the modulatory effect of the intraoperative administration of dexmedetomidine or lidocaine with a sham control group (normal saline solution) on surgery-induced BBB disruption.

Timeline

Start
2023-10-25
Primary completion
2024-11-30
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.3 ug/kg Intravenous
Subject Lidocaine Other / unclassified 1.5 mg/kg Intravenous

Indications